Turn Therapeutics Statistics

Total Valuation

TTRX has a market cap or net worth of $107.24 million. The enterprise value is $104.33 million.

Market Cap	107.24M
Enterprise Value	104.33M

Important Dates

The next estimated earnings date is Thursday, May 14, 2026, after market close.

Earnings Date	May 14, 2026
Ex-Dividend Date	n/a

Share Statistics

TTRX has 29.79 million shares outstanding. The number of shares has increased by 4.03% in one year.

Current Share Class	29.79M
Shares Outstanding	29.79M
Shares Change (YoY)	+4.03%
Shares Change (QoQ)	+1.61%
Owned by Insiders (%)	57.78%
Owned by Institutions (%)	1.69%
Float	11.13M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	23.25
P/TBV Ratio	29.04
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.87, with a Debt / Equity ratio of 0.02.

Current Ratio	0.87
Quick Ratio	0.85
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -141.67% and return on invested capital (ROIC) is -168.65%.

Return on Equity (ROE)	-141.67%
Return on Assets (ROA)	-55.90%
Return on Invested Capital (ROIC)	-168.65%
Return on Capital Employed (ROCE)	-103.20%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$1.60M
Employee Count	2
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	3.45
200-Day Moving Average	n/a
Relative Strength Index (RSI)	57.78
Average Volume (20 Days)	27,050

Short Selling Information

The latest short interest is 60,219, so 0.20% of the outstanding shares have been sold short.

Short Interest	60,219
Short Previous Month	63,128
Short % of Shares Out	0.20%
Short % of Float	0.54%
Short Ratio (days to cover)	2.21

Income Statement

Revenue	n/a
Gross Profit	-496,948
Operating Income	-6.36M
Pretax Income	-3.19M
Net Income	-3.19M
EBITDA	-6.30M
EBIT	-6.36M
Earnings Per Share (EPS)	-$0.12

Full Income Statement

Balance Sheet

The company has $5.08 million in cash and $80,376 in debt, giving a net cash position of $5.00 million or $0.17 per share.

Cash & Cash Equivalents	5.08M
Total Debt	80,376
Net Cash	5.00M
Net Cash Per Share	$0.17
Equity (Book Value)	4.69M
Book Value Per Share	0.16
Working Capital	-806,980

Full Balance Sheet

Cash Flow

Operating Cash Flow	-2.56M
Capital Expenditures	n/a
Depreciation & Amortization	52,746
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TTRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.03%
Shareholder Yield	-4.03%
Earnings Yield	-2.92%
FCF Yield	n/a

Analyst Forecast

The average price target for TTRX is $8.00, which is 122.22% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.00
Price Target Difference	122.22%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1